Assessing the effect of seasonal malaria chemoprevention on malaria burden among children under 5 years in Burkina Faso
- PMID: 35524310
- PMCID: PMC9074217
- DOI: 10.1186/s12936-022-04172-z
Assessing the effect of seasonal malaria chemoprevention on malaria burden among children under 5 years in Burkina Faso
Abstract
Background: In 2014, the Burkina Faso government launched the Seasonal Malaria Chemoprevention (SMC) programme. Expected benefit was a 75% reduction of all malaria episodes and a 75% drop of severe malaria episodes. This study assessed SMC efficiency on malaria morbidity in the country after 2 years of implementation.
Methods: Quasi-experimental design comparing changes in outcomes during the high transmission period (August-November) between SMC and non-SMC health districts before (2013-2014) and after intervention (two rounds in 2015 and 2016). Health indicators (number of uncomplicated malaria cases (UM) and severe malaria cases (SM)) from 19 health districts (8 in intervention and 11 in comparison group) were extracted from the District Health Information System (DHIS2)-based platform including health facilities data. Effect on incidence was assessed by fitting difference-in difference mixed-effects negative binomial regression model at a log scale.
Results: The two rounds of SMC were associated with a reduction of UM incidence (ratio of incidence rate ratio (IRR) 69% (95% CI 55-86%); p = 0.001) and SM incidence (ratio of IRR = 73% (55-95%), p = 0.018) among under five children.
Conclusion: The two rounds of SMC had a significant effect on the reduction of malaria cases in under five children. This additional evidence on the effectiveness of SMC, using routine data, support the need to sustain its implementation and consider expansion to eligible areas not yet covered.
Keywords: Burkina Faso; Evaluation; Impact; Malaria; Seasonal malaria chemoprevention.
© 2022. The Author(s).
Conflict of interest statement
The authors do not have any conflict of interest.
Figures




Similar articles
-
Evaluation of seasonal malaria chemoprevention in two areas of intense seasonal malaria transmission: Secondary analysis of a household-randomised, placebo-controlled trial in Houndé District, Burkina Faso and Bougouni District, Mali.PLoS Med. 2020 Aug 21;17(8):e1003214. doi: 10.1371/journal.pmed.1003214. eCollection 2020 Aug. PLoS Med. 2020. PMID: 32822362 Free PMC article. Clinical Trial.
-
Impact of seasonal RTS,S/AS01E vaccination plus seasonal malaria chemoprevention on the nutritional status of children in Burkina Faso and Mali.Malar J. 2022 Feb 22;21(1):59. doi: 10.1186/s12936-022-04077-x. Malar J. 2022. PMID: 35193608 Free PMC article. Clinical Trial.
-
Enhanced effect of seasonal malaria chemoprevention when coupled with nutrients supplementation for preventing malaria in children under 5 years old in Burkina Faso: a randomized open label trial.Malar J. 2023 Oct 18;22(1):315. doi: 10.1186/s12936-023-04745-6. Malar J. 2023. PMID: 37853408 Free PMC article. Clinical Trial.
-
Effect of seasonal malaria chemoprevention in children between 5 and 9 years old in Kita and Bafoulabe districts, Mali.Parasite Epidemiol Control. 2022 Jun 22;18:e00258. doi: 10.1016/j.parepi.2022.e00258. eCollection 2022 Aug. Parasite Epidemiol Control. 2022. PMID: 35789762 Free PMC article. Review.
-
Seasonal malaria chemoprevention in Africa and China's upgraded role as a contributor: a scoping review.Infect Dis Poverty. 2023 Jul 5;12(1):63. doi: 10.1186/s40249-023-01115-x. Infect Dis Poverty. 2023. PMID: 37403183 Free PMC article.
Cited by
-
Assessing the Impact of Relapse, Reinfection and Recrudescence on Malaria Eradication Policy: A Bifurcation and Optimal Control Analysis.Trop Med Infect Dis. 2022 Sep 24;7(10):263. doi: 10.3390/tropicalmed7100263. Trop Med Infect Dis. 2022. PMID: 36288004 Free PMC article.
-
Evolution of Pfdhps and Pfdhfr mutations before and after adopting seasonal malaria chemoprevention in Nanoro, Burkina Faso.Sci Rep. 2024 Oct 16;14(1):24224. doi: 10.1038/s41598-024-75369-2. Sci Rep. 2024. PMID: 39414909 Free PMC article.
-
Evaluating artesunate monotherapy and dihydroartemisinin-piperaquine as potential antimalarial options for prevaccination radical cures during future malaria vaccine field efficacy trials.Malar J. 2024 Dec 18;23(1):377. doi: 10.1186/s12936-024-05198-1. Malar J. 2024. PMID: 39695728 Free PMC article. Clinical Trial.
-
Malaria prevention in children: an update.Curr Opin Pediatr. 2024 Apr 1;36(2):164-170. doi: 10.1097/MOP.0000000000001332. Epub 2024 Jan 22. Curr Opin Pediatr. 2024. PMID: 38299986 Free PMC article. Review.
-
Factors Influencing Second and Third Dose Observance during Seasonal Malaria Chemoprevention (SMC): A Quantitative Study in Burkina Faso, Mali and Niger.Trop Med Infect Dis. 2022 Aug 29;7(9):214. doi: 10.3390/tropicalmed7090214. Trop Med Infect Dis. 2022. PMID: 36136625 Free PMC article.
References
-
- Ministère de la Santé. Directives nationales pour la prise en charge du paludisme dans les formations sanitaires du Burkina Faso. Programme National de Lutte contre le Paludisme; 2014. https://www.severemalaria.org/sites/mmv-smo/files/content/attachments/20....
-
- WHO. Policy recommendation: seasonal malaria chemoprevention (SMC) for Plasmodium falciparum malaria control in highly seasonal transmission areas of the Sahel sub-region in Africa. Geneva: World Health Organization; 2012. https://apps.who.int/iris/handle/10665/337978.
-
- WHO. Policy recommendation on intermittent preventive treatment during infancy with sulphadoxine–pyrimethamine (SP-IPTi) for Plasmodium falciparum malaria control in Africa. Geneva: World Health Organization; 2010. https://apps.who.int/iris/handle/10665/337977.
-
- WHO. Report of the technical consultation on seasonal malaria chemoprevention (SMC)/Chimio-prévention saisonnière du paludisme (CSP). Geneva: World Health Organization; 2011. https://www.who.int/malaria/publications/atoz/smc_report_teg_meetingmay2....
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical